Its overexpression is associated with chemoresistance, whereas CIP2A silencing sensitizes NSCLC cells to cisplatin, suppresses proliferation and colony formation, and promotes apoptosis, accompanied by reduced Akt activation [25]. The gene discussed is CIP2A; the disease is non-small cell lung carcinoma.